103
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Health benefits of reducing ambient levels of fine particulate matter: a mortality impact assessment in Taiwan

&

References

  • Altieri, K. E., and S. L. Keen. 2019. Public health benefits of reducing exposure to ambient fine particulate matter in South Africa. Sci. Total Environ. 684:610–20. doi:10.1016/j.scitotenv.2019.05.355.
  • Aryal, A., A. C. Harmon, and T. R. Dugas. 2021. Particulate matter air pollutants and cardiovascular disease: Strategies for intervention. Pharmacol. Ther. 223:107890. doi:10.1016/j.pharmthera.2021.107890.
  • Atkinson, R. W., A. Cohen, S. Mehta, and H. R. Anderson. 2012. Systematic review and meta-analysis of epidemiologic time-series studies on outdoor air pollution and health in Asia. Air Qual. Atmos. Health 5 (4):383–91. doi:10.1007/s11869-010-0123-2.
  • Bai, H., W. Gao, Y. Zhang, and L. Wang. 2022. Assessment of health benefits of PM2.5 reduction during COVID-19 lockdown in China and separating contributions from anthropogenic emissions and meteorology. J. Environ. Sci. 115:422–31. doi:10.1016/j.jes.2021.01.022.
  • Ballester, F., S. Medina, E. Boldo, P. Goodman, M. Neuberger, C. Iniguez, and N. Kunzli. 2008. Reducing ambient levels of fine particulates could substantially improve health: A mortality impact assessment for 26 European cities. J. Epidemiol. Commun. Health 62 (2):98–105. doi:10.1136/jech.2007.059857.
  • Basith, S., B. Manavalan, T. H. Shin, C. B. Park, W.-S. Lee, J. Kim, and G. Lee. 2022. The impact of fine particulate matter 2.5 on the cardiovascular system: A review of the invisible killer. Nanomater. 12 (15):2656. doi:10.3390/nano12152656.
  • Beelen, R., O. Raaschou-Nielsen, M. Stafoggia, Z. J. Anderson, G. Weinmayr, B. Hoffmann, K. Wolf, E. Samoli, P. Fischer, M. Nieuwenhuijsen, et al. 2014. Effects of long-term exposure to air pollution on natural-cause mortality: An analysis of 22 European cohorts within the multicentre ESCAPE project. Lancet. 383(9919):785–95. doi:10.1016/S0140-6736(13)62158-3.
  • Berman, J. D., N. Fann, J. W. Hollingsworth, K. E. Pinkerton, W. N. Rom, A. M. Szema, P. N. Breysse, R. H. White, and F. C. Curriero. 2012. Health benefits from large-scale ozone reduction in the United States. Environ. Health Perspect. 120 (10):1404–10. doi:10.1289/ehp.1104851.
  • Boldo, E., S. Medina, A. LeTertre, F. Hurley, H. G. Mucke, F. Ballester, and I. Aguilera. 2006. Apheis: Health impact assessment of long- term exposure to PM2.5 in 23 European cities. Eur. J. Epidemiol. 21 (6):449–58. doi:10.1007/s10654-006-9014-0.
  • Brook, R. D., S. Cakmak, M. C. Turner, J. R. Brook, D. L. Crouse, P. A. Peters, A. van Donkelaar, P. J. Villeneuve, O. Brion, M. Jerrett, et al. 2013. Long-term fine particulate matter exposure and mortality from diabetes in Canada. Biointer. Diabetes Care. 36(10):3313–20. doi:10.2337/dc12-2189.
  • Broome, R. A., N. Fann, T. J. N. Cristina, C. Fulcher, H. Duc, and G. G. Morgan. 2015. The health benefits of reducing air pollution in Sydney, Australia. Environ. Res 143:19–25. doi:10.1016/j.envres.2015.09.007.
  • Chanel, O., L. Perez, N. Künzli, S. Medina, and Aphekom group. 2016. The hidden economic burden of air pollution-related morbidity: Evidence from the aphekom project. Eur J. Health Econ. 17 (9):1101–15. doi:10.1007/s10198-015-0748-z.
  • Chen, C. C., P. S. Chen, and C. Y. Yang. 2019. Relationship between fine particulate air pollution and life expectancy in humans in Taiwan. J. Toxicol. Environ. Health Part A 82 (14):826–32. doi:10.1080/15287394.2019.1658386.
  • Chen, L., M. Shi, S. Gao, S. Li, J. Mao, H. Zhang, Y. Sun, Z. Bai, and Z. Wang. 2017. Assessment of population exposure to PM2.5 for mortality in China and its public health benefit based on BenMAP. Environ. Pollut. 221:311–17. doi:10.1016/j.envpol.2016.11.080.
  • Chiu, H. F., M. H. Cheng, S. S. Tsai, T. N. Wu, H. W. Kuo, and C. Y. Yang. 2006. Outdoor air pollution and female lung cancer in Taiwan. Inhal Toxicol. 18 (13):1025–31. doi:10.1080/08958370600904561.
  • Chiu, H. F., S. C. Ho, and C. Y. Yang. 2004. Lung cancer mortality reduction after installation of tap-water supply system in an arseniasis-endemic area in southwestern Taiwan. Lung Cancer 46 (3):265–70. doi:10.1016/j.lungcan.2004.05.012.
  • Colin, G., L. Peterson, C. Hogrefe, A. E. Corrigan, L. M. Neas, and R. Mathur. 2020. Impact of reductions in emissions from major source sectors on fine particulate matter–related cardiovascular mortality. Environ. Health Perspect 128 (1):17005. doi:10.1289/EHP5692.
  • Corrigan, A. E., M. M. Becker, L. M. Neas, W. E. Cascio, and A. G. Rappold. 2018. Fine particulate matters: The impact of air quality standards on cardiovascular mortality. Environ. Res. 161:364–69. doi:10.1016/j.envres.2017.11.025.
  • Crouse, D. I., P. A. Peters, A. van Donkelaar, M. S. Goldberg, P. J. Villeneuve, O. Brion, S. Khan, D. O. Atari, M. Jerrett, C. A. Pope, et al. 2012. Risk of nonaccidental and cardiovascular mortality in relation to long-term exposure to low concentrations of fine particulate matter: A Canadian national-level cohort study. Environ. Health Perspect. 120(5):708–14. doi:10.1289/ehp.1104049.
  • Davidson, K., A. Hallberg, D. McCubbin, and B. Hubbell. 2007. Analysis of PM 2.5 using the environmental benefits mapping and analysis program (BenMAP). J. Toxicol. Environ. Health Part A 70 (3–4):332–46. doi:10.1080/15287390600884982.
  • Fann, N., K. R. Baker, and C. M. Fulcher. 2012a. Characterizing the PM2.5-related health benefits of emission reductions for 17 industrial area and mobile emission sectors across the U.S. Environ. Int. 49:141–51. doi:10.1016/j.envint.2012.08.017.
  • Fann, N., M. I. Bell, K. Walker, and B. Hubbell. 2011. Improving the linkages between air pollution epidemiology and quantitative risk assessment. Environ. Health Perspect. 119 (12):1671–75. doi:10.1289/ehp.1103780.
  • Fann, N., S. Y. Kim, C. Olives, and L. Sheppard. 2017. Estimated changes in life expectancy and adult mortality resulting from declining PM2.5 exposures in the contiguous United States: 1980–2010. Environ. Health Perspect. 125 (9):097003. doi:10.1289/EHP507.
  • Fann, N., Lamson, A.D., Anenberg, S.C., Wesson, K., Risley, D., and Hubbell, B.J. 2012b Estimating the national public health burden associated with exposure to PM2.5 and ozone. Risk Anal. 32 81–95
  • Forouzanfar, M. H., A. Afshin, L. T. Alexander, S. Cercy, M. Brauer, K. Biryukov, M. Brauer, R. Burnett, K. Cercy, F. J. Charlson, et al. 2016. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: A systematic analysis for the global burden of disease study 2015. Lancet. 388(10053):1659–724. doi:10.1016/S0140-6736(16)31679-8.
  • Forouzanfar, M. H., L. Alexander, H. R. Anderson, V. F. Bachman, S. Biryukov, M. Brauer, R. Burnett, D. Casey, M. M. Coates, A. Cohen, et al. 2015. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: A systematic analysis for the global burden of disease study 2013. Lancet 386 (10010):2287–323. doi:10.1016/S0140-6736(15)00128-2.
  • Health Effects Institute. 2003. Assessing health impact of air quality regulations: Concepts and methods for accountability research. Boston: Health Effects Institute.
  • Henneman, L. R., C. Choirat, and C. M. Zigler. 2019. Accountability assessment of health improvements in the United States associated with reduced coal emissions between 2005 and 2012. Epidemiol. 30 (4):477–85. doi:10.1097/EDE.0000000000001024.
  • Howard, D. B., J. The, R. Soria, N. Fann, R. Schaeffer, and J. D. M. Saphores. 2019. Health benefits and control costs of tightening particulate matter emissions stands for coal power plants- the case of Northeast Brazil. Environ Int. 124:420–30. doi:10.1016/j.envint.2019.01.029.
  • Jerrett, M., R. T. Burnett, R. Ma, C. A. Pope, D. Krewski, K. B. Newbold, G. Thurston, Y. Shi, N. Finkelstein, E. E. Calle, et al. 2005. Spatial analysis of air pollution and mortality in Los Angeles. Epidemiol. 16(6):727–36. doi:10.1097/01.ede.0000181630.15826.7d.
  • Kong, H. K., D. K. Yoon, H. W. Lee, and C. M. Lee. 2021. Evaluation of particulate matter concentrations according to cooking activity in a residential environment. Environ. Sci. Pollut. Res. 28 (2):2443–56. doi:10.1007/s11356-020-10670-x.
  • Krewski, D., M. Jerrett, R. T. Burnett, R. Ma, E. Hughes, Y. Shi, M. C. Turner, C. A. Pope. 2009. Extended follow-up and spatial analysis of the American cancer society study linking particulate air pollution and mortality. Boston, MA: Health Effects Institute.
  • Li, J., Y. Zhu, J. T. Kelly, C. J. Jang, S. Wang, A. Hanna, J. Xing, C. J. Lin, S. Long, L. Yu, et al. 2019. Health benefit assessment of PM2.5 reduction in pearl river delta region of China using a model-monitor data fusion approach. J. Environ. Manage. 233:489–98. doi:10.1016/j.jenvman.2018.12.060.
  • Lo, W. C., R. H. Shie, C. C. Chan, and H. H. Lin. 2017. Burden of disease attributable to ambient fine particulate matter exposure in Taiwan. J. Formosan Med. Assoc 116 (1):32–40. doi:10.1016/j.jfma.2015.12.007.
  • Malqvist, E., A. Qudin, M. Pascal, and S. Medina. 2018. Choices behind numbers: A review of the major air pollution health impact assessment in Europe. Curr. Environ. Health Rep. 5 (1):34–43. doi:10.1007/s40572-018-0175-2.
  • Manojkumar, N., and B. Srimuruganandam. 2021. Health benefits of achieving fine particulate matter standards in India- a nationwide assessment. Sci. Total Environ. 763:142999. doi:10.1016/j.scitotenv.2020.142999.
  • Nhung, N. T. T., E. Jegasothy, N. T. K. Ngan, N. X. Truong, N. T. N. Thanh, G. B. Marks, and G. G. Morgan. 2022. Mortality burden due to exposure to outdoor fine particulate in Hanoi, Vietnam: Health impact assessment. Int. J. Public Health 67:1604331. doi:10.3389/ijph.2022.1604331.
  • Ni, Y., G. Shi, and J. Qu. 2020. Indoor PM2.5 tobacco smoking and chronic lung diseases: A narrative review. Environ. Res. 181:108910. doi:10.1016/j.envres.2019.108910.
  • Pascal, M., M. Corso, O. Chanel, C. Declercq, C. Badaloni, G. Cesaroni, S. Henschel, K. Meister, D. Haluza, P. Martin-Olmedo, et al. 2013. Assessing the public health impacts of urban air pollution in 25 European cities: Results of the aphekom project. Sci. Total Environ. 449:390–400. doi:10.1016/j.scitotenv.2013.01.077.
  • Pope, C. A., R. T. Burnett, M. J. Thun, E. E. Calle, D. Krewski, K. Ito, and G. D. Thurston. 2002. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. J. Am. Med. Assoc. 287 (9):1132–41. doi:10.1001/jama.287.9.1132.
  • Pope, C. A., D. W. Dockery, and J. Schwartz. 1995. Review of epidemiologic evidence of health effects of particulate air pollution. Inhal Toxicol. 7 (1):1–18. doi:10.3109/08958379509014267.
  • Reynolds, P., J. V. Behren, R. B. Gunier, D. E. Goldberg, A. Hertz, and D. F. Smith. 2003. Childhood cancer incidence rates and hazardous air pollutants in California: An exploratory analysis. Environ. Health Perspect. 111 (4):663–68. doi:10.1289/ehp.5986.
  • Rittner, R., E. Flanagan, A. Oudin, and E. Malmqvist. 2020. Health impacts from ambient particle exposure in Southern Sweden. Int. J. Environ. Res. 17 (14):5064. doi:10.3390/ijerph17145064.
  • Sacks, J. D., J. M. Lloydb, Y. Zhuc, J. Andertond, C. J. Jange, B. Hubbellf, and N. Fann. 2018. The environmental benefits mapping and analysis program – community edition (BenMAP–CE): A tool to estimate the health and economic benefits of reducing air pollution. Environ. Model 104:118–29. doi:10.1016/j.envsoft.2018.02.009.
  • Shkirkova, K., K. Lamorie-Foote, M. Connor, A. Patel, G. Barisano, H. Baertsch, Q. Liu, T. E. Morgan, C. Sioutas, W. J. Mack, et al. Effects of ambient particulate matter on vascular tissue: A review. J. Toxicol. Environ. Health B 23(7):319–50. doi:10.1080/10937404.2020.1822971.
  • Sidwell, A., S. C. Smith, and C. Roper. 2022. A comparison of fine particulate matter (PM2.5) in vivo exposure studies incorporating chemical analysis. J. Toxicol. Environ. Health B 25 (8):422–44. doi:10.1080/10937404.2022.2142345.
  • Thangavel, P., D. Park, and Y. C. Lee. 2022. Recent insights into particulate matter (PM2.5)-mediated toxicity in humans: An overview. Int. J. Environ. Res. 19 (12):7511. doi:10.3390/ijerph19127511.
  • Tomczak, A., A. B. Miller, S. A. Weichenthal, T. To, A. Martin, R. V. van Donkelaar, D. L. Crouse, P. J. Villeneuve, and P. J. Villeneuve. 2016. Long-term exposure to fine particulate matter air pollution and the risk of lung cancer among participants of the Canadian national breast screening study. Int. J. Cancer 139 (9):1958–66. doi:10.1002/ijc.30255.
  • Tsai, S. S., Y. W. Chiu, Y. H. Weng, and C. Y. Yang. 2022. Association between fine particulate air pollution and the risk of death from lung cancer in Taiwan. J. Toxicol. Environ. Health Part A 85 (10):431–38. doi:10.1080/15287394.2022.2040672.
  • van der Kamp, J., and T. M. Bachmann. 2015. Health-related external cost assessment in Europe: Methodological development from to externE to the 2013 clean air policy package. Environ. Sci. 40 (5):2929–38. doi:10.1021/es5054607.
  • Vodonos, A., Y. A. Awad, and J. Schwartz. 2018. The concentration- response between long-term PM2.5 exposure and mortality: A meta- regression approach. Environ. Res. 166:677–89. doi:10.1016/j.envres.2018.06.021.
  • Wang, Y., I. Kloog, B. A. Coull, A. Kosheleva, A. Zanobetti, and J. D. Schwartz. 2016. Estimating causal effects of long-term PM 2.5 exposure on mortality in New Jersey. Environ. Health Perspect. 124 (8):1182–88. doi:10.1289/ehp.1409671.
  • Wichmann, J., and K. V. V. Voyi. 2005. Air pollution epidemiological studies in South Africa: Need for freshening up. Rev. Environ. Health 20 (4):265–301. doi:10.1515/REVEH.2005.20.4.265.
  • World Bank. 2016. The cost of air pollution: Strengthening the economic case for action. Washington, D.C: World Bank.
  • World Health Organization (WHO). 1999. European center for health policy. Health impact assessment: Main concepts and suggested approach. Copenhagen: Regional office for Europe, WHO.
  • World Health Organization (WHO). 2000. Evaluation and use of epidemiological evidence for environmental risk assessment. Regional office for Europe, WHO. EUR/00/5020369.
  • World Health Organization (WHO). 2001. Quantification of health effects of exposure to air pollution. Regional office for Europe, WHO. EUR/01/5026342.
  • World Health Organization (WHO). 2006. Air quality guidelines: Global update 2005: Particulate matter, ozone, nitrogen dioxide, and sulfur dioxide. Copenhagen: Regional office for Europe, WHO.
  • World Health Organization (WHO). 2013. Review of evidence on health aspects of air pollution- REVIHAAP Project. Final technical report. Geneva: WHO.
  • Yang, C. Y. 1998. Calcium and magnesium in drinking water and risk of death from cerebrovascular disease. Stroke 29 (2):411–14. doi:10.1161/01.STR.29.2.411.
  • Yang, C. Y., J. F. Chiu, H. F. Chiu, T. N. Wang, C. H. Lee, and Y. C. Ko. 1996. Relationship between water hardness and coronary mortality in Taiwan. J. Toxicol. Environ. Health 49 (1):1–9. doi:10.1080/009841096160952.
  • Yang, P., Y. Zhang, K. Wang, P. Doraiswamy, and S. H. Cho. 2019. Health impacts and cost-benefit analyses of surface O3 and PM2.5 over the U.S. under future climate and emission scenarios. Environ. Res. 178:108687. doi:10.1016/j.envres.2019.108687.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.